GRI Bio GRI
NASDAQ GRI
$1.47 +0.01 (+0.68%)
At close: Oct 21, 2026 · 4:00 PM EDT

GRI Bio (GRI) EV to CFO (2023)

Updated

GRI Bio's EV to CFO was 215.26 in Q1 2023.

Analysis

GRI Bio (GRI) EV to CFO (2023) Analysis & Trends

On a trailing twelve-month basis, GRI Bio's EV to CFO was 195.89 through Mar 31, 2023.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 GRI Bio 2.65 Mn -31.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 215.26
API Access

GRI Bio EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=GRI&period=max&api_key=YOUR_API_KEY